
    
      Intervention:

        -  Study A: Subjects with biopsy proven sarcoidosis suspected of cardiac involvement (prone
           to arrhythmias, cardiac failure, unexplained dyspnea) are studied twice: 1) 18-FDG PET
           preceded by 12 hours fasting and 2) 18-FDG PET performed during a 2 hour somatostatin
           blockade (300 microgram/hour)/Heparin infusion.

        -  Study B: Subjects with biopsy proven sarcoidosis suspected of cardiac involvement are
           studied twice: 1) 18-FDG PET preceded by 12 hours fasting and 2) 68Ga-DOTANOC PET
           preceded by at least 6 hours fasting.
    
  